• 1
    Shanmugaratnam K, Sobin LH. Histological typing of tumors of the upper respiratory tract and ear, 2nd ed. Berlin: Springer-Verlag, 1991. 323.
  • 2
    Bailar JC. Nasopharyngeal cancer in white populations: a world survey. In: MuirCS, ShanmugaratnamK,eds. Cancer of the nasopharynx. New York: Medical Examination Publishing, 1967. 1823.
  • 3
    Ho JH. Nasopharyngeal carcinoma (NPC). Adv Cancer Res 1972; 15: 5792.
  • 4
    Waterhouse J, Muir C, Correa P, Puwell J. Cancer incidence in five continents, Vol. III. IARC Scientific Publication No. 15, Lyon 1976.
  • 5
    Department of Health, Executive Yuan, Republic of China. Annual report of cancer registration, 1982–1985. Taipei: Department of Health, Executive Yuan, 1986.
  • 6
    Buell P. The effect of migration on the risk of nasopharyngeal cancer among Chinese. Cancer Res 1974; 34: 118991.
  • 7
    Muir CS. Nasopharyngeal carcinoma in non-Chinese populations with special reference to south-east Asia and Africa. Int J Cancer 1971; 8: 35163.
  • 8
    Yu MC, Ho JH, Lai SH, Henderson BE. Cantonese-style salted fish as a cause of nasopharyngeal carcinoma: report of a case-control study in Hong Kong. Cancer Res 1986; 46: 95661.
  • 9
    Hildesheim A, Chen CJ, Caporaso NE, Cheng YJ, Hoover RN, Hsu MM, Levine PH, Chen IH, Chen JY, Yang CS. Cytochrome P4502E1 genetic polymorphisms and risk of nasopharyngeal carcinoma: results from a case-control study conducted in Taiwan. Cancer Epidemiol Biomarkers Prev 1995; 4: 60710.
  • 10
    Chen CJ, Liang KY, Chang YS, Wang YF, Hsieh T, Hsu MM, Chen JY, Liu MY. Multiple risk factors of nasopharyngeal carcinoma: Epstein-Barr virus, malarial infection, cigarette smoking and familial tendency. Anticancer Res 1990; 10: 54753.
  • 11
    Ward MH, Pan WH, Cheng YJ, Li FH, Brinton LA, Chen CJ, Hsu MM, Chen IH, Levine PH, Yang CS, Hildesheim A. Dietary exposure to nitrite and nitrosamines and risk of nasopharyngeal carcinoma in Taiwan. Int J Cancer 2000; 86: 6039.
  • 12
    Vaughan TL, Shapiro JA, Burt RD, Swanson GM, Berwick M, Lynch CF, Lyon JL. Nasopharyngeal cancer in a low-risk population: defining risk factors by histological type. Cancer Epidemiol Biomarkers Prev 1996; 5: 58793.
  • 13
    Klein G, Giovanella BC, Lindahl T, Fialkow PJ, Singh S, Stehlin JS. Direct evidence for the presence of Epstein-Barr virus DNA and nuclear antigen in malignant epithelial cells from patients with poorly differentiated carcinoma of the nasopharynx. Proc Natl Acad Sci USA 1974; 71: 473741.
  • 14
    Tsai ST, Jin YT, Su IJ. Expression of EBER1 in primary and metastatic nasopharyngeal carcinoma tissues using in situ hybridization. A correlation with WHO histologic subtypes. Cancer 1996; 77: 2316.
  • 15
    Simons MJ, Wee GB, Day NE, Morris PJ, Shanmugaratnam K, de-Thé GB. Immunogenetic aspects of nasopharyngeal carcinoma: I. Differences in HL-A antigen profiles between patients and control groups. Int J Cancer 1974; 13: 12234.
  • 16
    Chan SH, Day NE, Kunaratnam N, Chia KB, Simons MJ. HLA and nasopharyngeal carcinoma in Chinese—a further study. Int J Cancer 1983; 32: 1716.
  • 17
    Simons MJ, Wee GB, Chan SH, Shanmugaratnam K. Probable identification of an HL-A second-locus antigen associated with a high risk of nasopharyngeal carcinoma. Lancet 1975; 1: 1423.
  • 18
    Cui SH, Lin Y. Correlation between nasopharyngeal carcinoma and HLA phenotype [in Chinese]. Zhong Hua Zhong Liu Za Zhi 1982; 4: 24953.
  • 19
    Ou BX, Ruan HY, Fang Y, Liu LM, Li ZQ, Zhang F. Study on association between HLA-A, B, C, DR and nasopharyngeal carcinoma (NPC) in Guangzhou area [in Chinese]. Ai Zheng 1985; 4: 57.
  • 20
    Chan SH, Chew CT, Prasad U, Wee GB, Srinivasan N, Kunaratnam N. HLA and nasopharyngeal carcinoma in Malays. Br J Cancer 1985; 51: 38992.
  • 21
    Wu SB, Hwang SJ, Chang AS, Hsieh T, Hsu MM, Hsieh RP, Chen CJ. Human leukocyte antigen (HLA) frequency among patients with nasopharyngeal carcinoma in Taiwan. Anticancer Res 1989; 9: 164953.
  • 22
    Zhu X, Kong F, Chen R, Liu W. Human leukocyte antigens -A, -B, -C, and -DR and nasopharyngeal carcinoma in northern China. Ann Otol Rhinol Laryngol 1990; 99: 2867.
  • 23
    Burt RD, Vaughan TL, Nisperos B, Swanson M, Berwick M. A protective association between the HLA-A2 antigen and nasopharyngeal carcinoma in US Caucasians. Int J Cancer 1994; 56: 4657.
  • 24
    Ren EC, Law GC, Chan SH. HLA-A2 allelic microvariants in nasopharyngeal carcinoma. Int J Cancer 1995; 63: 2135.
  • 25
    Burt RD, Vaughan TL, McKnight B, Davis S, Beckmann AM, Smith AG, Nisperos B, Swanson M, Berwick M. Associations between human leukocyte antigen type and nasopharyngeal carcinoma in Caucasians in the United States. Cancer Epidemiol Biomarkers Prev 1996; 5: 87987.
  • 26
    Lu SJ, Day NE, Degos L, Lepage V, Wang PC, Chan SH, Simons M, McKnight B, Easton D, Zeng Y, de-Thé G. Linkage of a nasopharyngeal carcinoma susceptibility locus to the HLA region. Nature 1990; 346: 4701.
  • 27
    Ooi EE, Ren EC, Chan SH. Association between microsatellites within the human MHC and nasopharyngeal carcinoma. Int J Cancer 1997; 74: 22932.
  • 28
    Foissac A, Salhi M, Cambon-Thomsen A. Microsatellites in the HLA region: 1999 update. Tissue Antigens 2000; 55: 477509.
  • 29
    Svejgaard A, Platz P, Ryder LP. HLA and disease 1982—a survey. Immunol Rev 1983; 70: 193218.
  • 30
    Thorsby E. Invited anniversary review. HLA associated diseases. Hum Immunol 1997; 53: 111.
  • 31
    Feltkamp TE, Khan MA, Lopez de Castro JA. The pathogenic role of HLA-B27. Immunol Today 1996; 17: 57.
  • 32
    Dessen A, Lawrence CM, Cupo S, Zaller DM, Wiley DC. X-ray crystal structure of HLA-DR4 (DRA*0101, DRB1*0401) complexed with a peptide from human collagen II. Immunity 1997; 7: 47381.
  • 33
    Congia M, Frau F, Lampis R, Frau R, Mele R, Cucca F, Muntoni F, Porcu S, Boi F, Contu L, Nasa GL, Mulargia M, et al. A high frequency of the A30, B18, DR3, DRw52, DQw2 extended haplotype in Sardinian celiac disease patients: further evidence that the disease is conferred by DQ A1*0501, B1*0201. Tissue Antigens 1992; 39: 7883.
  • 34
    Jenisch S, Henseler T, Nair RP, Guo SW, Westphal E, Stuart P, Kronke M, Voorhees JJ, Christophers E, Elder JT. Linkage analysis of human leukocyte antigen (HLA) markers in familial psoriasis: strong disequilibrium effects provide evidence for a major determinant in the HLA-B/-C region. Am J Hum Genet 1998; 63: 1919.
  • 35
    Nair RP, Stuart P, Henseler T, Jenisch S, Chia NV, Westphal E, Schork NJ, Kim J, Lim HW, Christophers E, Voorhees JJ, Elder JT. Localization of psoriasis-susceptibility locus PSORS1 to a 60-kb interval telomeric to HLA-C. Am J Hum Genet 2000; 66: 183344.
  • 36
    Ota M, Mizuki N, Katsuyama Y, Tamiya G, Shiina T, Oka A, Ando H, Kimura M, Goto K, Ohno S, Inoko H. The critical region for Behçet disease in the human major histocompatibility complex is reduced to a 46-kb segment centromeric of HLA-B, by association analysis using refined microsatellite mapping. Am J Hum Genet 1999; 64: 140610.
  • 37
    Lu CC, Ye Y, She JX, Bonhomme F, Wakeland EK. Evolutionary origins of retroposon lineages of MHC class II Ab alleles. Immunogenetics 1996; 43: 11524.
  • 38
    Lu CC, Nguyen T, Morris S, Hill D, Sakanari JA. Anisakis simplex: mutational bursts in the reactive site centers of serine protease inhibitors from an ascarid nematode. Exp Parasitol 1998; 89: 25761.
  • 39
    MHC Sequencing Consortium. Complete sequence and gene map of a human major histocompatibility complex. Nature 1999; 401: 9213.
  • 40
    Bodmer JG, Marsh SG, Albert ED, Bodmer WF, Bontrop RE, Dupont B, Erlich HA, Hansen JA, Mach B, Mayr WR, Parham P, Petersdorf EW, et al. Nomenclature for factors of the HLA system, 1998. Tissue Antigens 1999; 53: 40746.
  • 41
    Mattiuz PL, Ihde D, Piazza A, Ceppellini R, Bodmer WF. New approaches to the population genetics and segregation analysis of the HL-A system. In: TerasakiPI, ed. Histocompatibility testing 1970. Copenhagen: Munksgaard, 1970. 193205.
  • 42
    Svejgaard A, Ryder LP. HLA and disease associations: detecting the strongest association. Tissue Antigens 1994; 43: 1827.
  • 43
    Jorde LB. Linkage disequilibrium as a gene-mapping tool. Am J Hum Genet 1995; 56: 114.
  • 44
    Wang YF, Tsai SF, Hsu KH, You SL, Lee SS, Lin TM, Chen CJ. Epidemiological characteristics of malignant neoplasm in Taiwan: nasopharyngeal carcinoma. J Natl Public Health Assoc (ROC) 1989; 9: 1627.
  • 45
    Kano T. Outline review of the Taiwan archaeology and ethnology. Taipei: Historical Research Commission of Taiwan, 1955.
  • 46
    Busson P, Zhang Q, Guillon JM, Gregory CD, Young LS, Clausse B, Lipinski M, Rickinson AB, Tursz T. Elevated expression of ICAM1 (CD54) and minimal expression of LFA3 (CD58) in Epstein-Barr-virus-positive nasopharyngeal carcinoma cells. Int J Cancer 1992; 50: 8637.
  • 47
    Agathanggelou A, Niedobitek G, Chen R, Nicholls J, Yin W, Young LS. Expression of immune regulatory molecules in Epstein-Barr virus–associated nasopharyngeal carcinomas with prominent lymphoid stroma. Evidence for a functional interaction between epithelial tumor cells and infiltrating lymphoid cells. Am J Pathol 1995; 147: 115260.
  • 48
    Khanna R, Busson P, Burrows SR, Raffoux C, Moss DJ, Nicholls JM, Cooper L. Molecular characterization of antigen-processing function in nasopharyngeal carcinoma (NPC): evidence for efficient presentation of Epstein-Barr virus cytotoxic T-cell epitopes by NPC cells. Cancer Res 1998; 58: 3104.
  • 49
    Khanna R, Burrows SR, Nicholls J, Poulsen LM. Identification of cytotoxic T cell epitopes within Epstein-Barr virus (EBV) oncogene latent membrane protein 1 (LMP1): evidence for HLA A2 supertype-restricted immune recognition of EBV-infected cells by LMP1-specific cytotoxic T lymphocytes. Eur J Immunol 1998; 28: 4518.
  • 50
    Shaw CK, Chang TK, Chen SN, Wu S. HLA polymorphism and probability of finding HLA-matched unrelated marrow donors for Chinese in Taiwan. Tissue Antigens 1997; 50: 6109.
  • 51
    Chan AS, To KF, Lo KW, Mak KF, Pak W, Chiu B, Tse GM, Ding M, Li X, Lee JC, Huang DP. High frequency of chromosome 3p deletion in histologically normal nasopharyngeal epithelia from southern Chinese. Cancer Res 2000; 60: 536570.